TRINOMAB

Serial Number 79350028
Registration 7470062
700

Registration Progress

Application Filed
Jul 12, 2022
Under Examination
Approved for Publication
May 28, 2024
Published for Opposition
May 28, 2024
Registered
Aug 13, 2024

Trademark Image

TRINOMAB

Basic Information

Serial Number
79350028
Registration Number
7470062
Filing Date
July 12, 2022
Registration Date
August 13, 2024
Published for Opposition
May 28, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 13, 2024
Registration
Registered
Classes
035 042 044

Rights Holder

Zhuhai Trinomab Pharmaceutical Co., Ltd.

99
Address
Rm.110, 1/F., Plant Building 6,
No.6366 Zhuhai Avenue, Jinwan District, Zhuhai City, Guangdong
CN

Ownership History

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Original Applicant
99
CN

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Owner at Publication
99
CN

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Original Registrant
99
CN

Legal Representation

Attorney
Scot A. Duvall

USPTO Deadlines

Next Deadline
1736 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-13)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Mar 29, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 1, 2025 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Feb 1, 2025 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Nov 13, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 11, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
May 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 15, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 15, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
May 8, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 24, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 24, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 24, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 11, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Feb 21, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 21, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Oct 11, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 11, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 11, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 22, 2023 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jul 22, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 30, 2023 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Jun 28, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 28, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 27, 2023 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW Loading...
Jun 10, 2023 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Apr 29, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 28, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 26, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 23, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 19, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 16, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 035
Retail store services and wholesale distributorship services featuring veterinary pharmaceutical preparations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services and wholesale distributorship services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceutical preparations; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases
Class 042
Scientific research; technological research in the field of pharmaceuticals; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical project studies, namely, conducting scientific feasibility studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; chemistry services in the nature of chemist services; chemistry services, namely, consultation, research and advice; none of the above related to the treatment or prevention of cardiovascular diseases
Class 044
Hospital services; medical assistance; nursing, medical; medical, physical rehabilitation and physical therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services, namely, collection and preservation of human blood; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases

Classification

International Classes
035 042 044